Crinetics was founded by a team of scientists with a track record of drug discovery and development. We are dedicated to creating important new therapeutic options for patients with rare endocrine diseases.

Meet Us


R. Scott Struthers, Ph.D.

Founder & Chief Executive Officer

Marc Wilson

Chief Financial Officer

Alan S. Krasner, M.D.

Chief Medical Officer

Ajay Madan, Ph.D., D.A.B.T.

Chief Development Officer

Gina Ford, R.Ph, MBA

Vice President, Corporate Strategy & Commercial Planning

Adriana Cabré, MBA

Vice President of Human Resources

Stephen F. Betz, Ph.D.

Founder & Vice President, Biology

Yun-Fei (Frank) Zhu, Ph.D.

Founder & Vice President, Chemistry

R. Scott Struthers, Ph.D.

Founder & Chief Executive Officer

Matthew K. Fust

Board Member

Stephen Kaldor, Ph.D.

Board Member

Weston Nichols, Ph.D.

Board Member

Anne Klibanski, M.D.

Scientific Advisory Board

David Clemmons, M.D.

Scientific Advisory Board

Philip Harris, FRCP, Ph.D.

Scientific Advisory Board